P

Inventor

PAYAN DONALD

US48 patents
⚠️ This page may combine multiple inventors who share the name “PAYAN DONALD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

RIGEL PHARMACEUTICALS INC

37 patents
US7820819B2Oct 26, 2010

2,4-pyrimidinediamine compounds and their uses

RIGEL PHARMACEUTICALS INC87 citations99
US7642351B2Jan 5, 2010

2,4-Pyrimidinediamine compounds and their uses

RIGEL PHARMACEUTICALS INC105 citations99
US7589200B2Sep 15, 2009

5-Fluoro-4N-phenyl-4-pyrimidineamine compounds

RIGEL PHARMACEUTICALS INC102 citations99
US7557210B2Jul 7, 2009

2,4-pyrimidinediamine compounds and their uses

RIGEL PHARMACEUTICALS INC190 citations99
US7550460B2Jun 23, 2009

2,4-pyrimidinediamine compounds and their uses

RIGEL PHARMACEUTICALS INC95 citations99
US7498435B2Mar 3, 2009

2,4-pyrimidinediamine compounds and their uses

RIGEL PHARMACEUTICALS INC93 citations99
US7485724B2Feb 3, 2009

2,4-pyrimidinediamine compounds and their uses

RIGEL PHARMACEUTICALS INC119 citations99
US7435814B2Oct 14, 2008

2,4-Pyrimidinediamine compounds and their uses

RIGEL PHARMACEUTICALS INC94 citations99
US7332484B2Feb 19, 2008

2,4-pyrimidinediamine compounds and their uses

RIGEL PHARMACEUTICALS INC146 citations99
US7329672B2Feb 12, 2008

2,4-pyrimidinediamine compounds and their uses

RIGEL PHARMACEUTICALS INC130 citations99
US7329671B2Feb 12, 2008

2,4-pyrimidinediamine compounds and their uses

RIGEL PHARMACEUTICALS INC147 citations99
US7060827B2Jun 13, 2006

Intermediates useful for making 2,4-pyrimidinediamine compounds

RIGEL PHARMACEUTICALS INC255 citations99
US7034145B2Apr 25, 2006

Directionally cloned random cDNA expression vector libraries, compositions and methods of use

RIGEL PHARMACEUTICALS INC164 citations98
US6455263B2Sep 24, 2002

Small molecule library screening using FACS

RIGEL PHARMACEUTICALS INC117 citations98
US6808906B2Oct 26, 2004

Directionally cloned random cDNA expression vector libraries, compositions and methods of use

RIGEL PHARMACEUTICALS INC63 citations96
US10941134B2Mar 9, 2021

AMPK-activating heterocyclic compounds and methods for using the same

RIGEL PHARMACEUTICALS INC18 citations94
US10377742B2Aug 13, 2019

AMPK-activating heterocyclic compounds and methods for using the same

RIGEL PHARMACEUTICALS INC20 citations94
US9913842B2Mar 13, 2018

2,4-pyrimidinediamine compounds and their uses

RIGEL PHARMACEUTICALS INC8 citations92
US9266856B2Feb 23, 2016

AMPK—activating heterocyclic compounds and methods for using the same

RIGEL PHARMACEUTICALS INC14 citations92
US8987303B2Mar 24, 2015

AMPK-activating heterocyclic compounds and methods for using the same

RIGEL PHARMACEUTICALS INC16 citations92
US8980921B2Mar 17, 2015

AMPK-activating heterocyclic compounds and methods for using the same

RIGEL PHARMACEUTICALS INC16 citations92
US8809370B2Aug 19, 2014

AMPK-activating heterocyclic compounds and methods for using the same

RIGEL PHARMACEUTICALS INC17 citations92
US6316223B1Nov 13, 2001

Mammalian protein interaction cloning system

RIGEL PHARMACEUTICALS INC29 citations92
US6114111ASep 5, 2000

Mammalian protein interaction cloning system

RIGEL PHARMACEUTICALS INC30 citations92
US9878992B2Jan 30, 2018

GDF-8 inhibitors

RIGEL PHARMACEUTICALS INC6 citations84
US6855495B1Feb 15, 2005

Toso as a target for drug screening

RIGEL PHARMACEUTICALS INC6 citations74
US9409884B2Aug 9, 2016

5- or 6-substituted benzofuran-2-carboxamide compounds and methods for using them

RIGEL PHARMACEUTICALS INC4 citations70
US6737240B1May 18, 2004

Methods of screening for a multi-drug resistance conferring peptide

RIGEL PHARMACEUTICALS INC7 citations70
US10709703B2Jul 14, 2020

2,4-pyrimidinediamine compounds and their uses

RIGEL PHARMACEUTICALS INC0 citations63
US6969584B2Nov 29, 2005

Combinatorial enzymatic complexes

RIGEL PHARMACEUTICALS INC5 citations63
US6897031B1May 24, 2005

Multiparameter FACS assays to detect alterations in exocytosis

RIGEL PHARMACEUTICALS INC6 citations62
US10858335B2Dec 8, 2020

2,3-Disubstituted pyridine compounds as TGF-β inhibitors and methods of use

RIGEL PHARMACEUTICALS INC0 citations52
US10233170B2Mar 19, 2019

2,3-disubstituted pyridine compounds as TGF-beta inhibitors and methods of use

RIGEL PHARMACEUTICALS INC0 citations52
US9518040B2Dec 13, 2016

GDF-8 inhibitors

RIGEL PHARMACEUTICALS INC0 citations52
US9511058B2Dec 6, 2016

Methods for using carboxamide, sulfonamide and amine compounds

RIGEL PHARMACEUTICALS INC0 citations52
US6555314B1Apr 29, 2003

Toso as a target for drug screening

RIGEL PHARMACEUTICALS INC1 citations52
US10040766B2Aug 7, 2018

Ubiquitination inhibitors

RIGEL PHARMACEUTICALS INC0 citations37

SINGH RAJINDER

6 patents

GOFF DANE

1 patent

BHAMIDIPATI SOMASEKHAR

1 patent

(unassigned)

1 patent

PAYAN DONALD

1 patent

FISHER JOSEPH

1 patent